Eric Leon Tam

Assistant Professor of Clinical Medicine

Medical Director of Inpatient BMT/Hematology Services

Image of Eric Leon Tam
Is this your profile? Click to edit

Education and Training

  • University of Southern California, Los Angeles — MBA — 05/2025 — Business Administration
  • Stanford University, Palo Alto, CA — 06/2020 — Bone Marrow Transplant Fellowship
  • SUNY Downstate, Brooklyn, NY — 06/2019 — Hematology Oncology Fellowship
  • NYC Health + Hospitals/Woodhull, Brooklyn, NY — 06/2016 — Internal Medicine Residency
  • St. George’s University, Grenada, WI — MD — 05/2013 — Doctor of Medicine
  • UCLA, Los Angeles, CA — BS — 05/2007 — Chemical Engineering

Publications

  • T lymphocytes and natural killer cells in myelodysplastic syndromes: function, dysfunction, and therapeutic potential. Front Immunol. 2026; 17:1907953.. View in PubMed
  • Optimizing venetoclax duration with hypomethylating agents for newly diagnosed acute myeloid leukemia: impact on response and survival. Ann Hematol. 2026 Aug 04; 105(10).. View in PubMed
  • Ivermectin Treatment for Strongyloides stercoralis-Associated Recurrence of Nongastric MALT Lymphoma. Case Rep Hematol. 2026; 2026:7226796.. View in PubMed
  • Pretransplant Blinatumomab Is Associated With Reduced Relapse and Improved Disease-Free Survival in Adults With B-Cell ALL Undergoing Allogeneic Hematopoietic Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2026 Aug; 26(8):562-573.e1.. View in PubMed
  • Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic Perspectives. Oncol Res. 2026; 34(3):4.. View in PubMed
  • Acute Myeloid Leukemia With a Non-Canonical FLT3 V491L Mutation: A Case Report With Ex Vivo FLT3 Inhibitors Sensitivity Testing. J Med Cases. 2026 Jan; 17(1):14-20.. View in PubMed
  • Combination of 2-Chlorodeoxyadenosine, Cytarabine, and Granulocyte Colony-Stimulating Factor and Venetoclax in a Case of Acute Myelogenous Leukemia. J Med Cases. 2025 Mar; 16(3):102-106.. View in PubMed
  • Combination Therapy With Asciminib and Ponatinib as a Bridge to Brexucabtagene Autoleucel and Maintenance in a Patient With Relapsed Refractory Philadelphia Positive B-Cell Acute Lymphoblastic Leukemia. J Med Cases. 2024 Oct; 15(10):261-266.. View in PubMed
  • Philadelphia-like B-cell acute lymphoblastic leukaemia: Disease features and outcomes in the era of immunotherapy. Br J Haematol. 2024 Dec; 205(6):2234-2247.. View in PubMed
  • Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus. Transplant Proc. 2024 Sep; 56(7):1671-1677.. View in PubMed